The Eye Believe Podcast

In this episode of Living in the Long-Middle, we are joined by Phil and Caitlyn Stewart, a husband-and-wife team sharing their experiences from both sides of the cancer journey—the patient perspective and the caregiver perspective. When cancer enters a relationship, it impacts more than just one person. Phil and Caitlyn offer an honest look at how they have navigated the challenges, uncertainties, and realities of ocular melanoma together. Through their conversation, they explore the unique roles of patient and caregiver, the importance of communication, and how partnership can provide strength during difficult times. Their story highlights the resilience that comes from facing adversity as a team and the lessons they have learned while living in the long-middle of cancer survivorship. Whether you are a patient, caregiver, family member, or friend, this episode offers meaningful insights into the power of support, understanding, and shared hope. 📱 Connect with Phil on the A Cure In Sight App!Username: philestewart_fMuFlrJ Download the ACIS App:https://acureinsight.org/a-cure-in-sight-acis-app/ Google Play:https://play.google.com/store/apps/details?id=com.createcommunity.acureinsight&pli=1 Apple App Store:https://apps.apple.com/au/app/a-cure-in-sight/id6748178227 Connect with Caitlyn:https://www.facebook.com/caitlyn.moran23 Learn more about the inspiration behind "Living in the Long-Middle":https://www.theguardian.com/society/2026/mar/22/i-have-stage-four-cancer-there-will-be-no-cure-but-death-isnt-necessarily-imminent-this-is-how-it-feels-to-live-in-the-long-middle Thank you to our sponsors for making this possible!-Ideaya Biosciences-Delcath Systems-Aura Biosciences-Castle Biosciences -Immunocore -Natera Learn more about A Cure In Sight:https://acureinsight.org Rare Cancer. Resilient Hope. Revolutionary Research. #OcularMelanoma #LivingInTheLongMiddle #CaregiverSupport #CancerSurvivorship #ACureInSight #PatientStories #CaregiverPerspective #EyeBelievePodcast

In this episode of What's Up, Doc? on the Eye Believe Podcast, we sit down with Dr. Miguel Materin, a leading ocular oncologist and retina specialist, for a conversation that goes beyond medicine. Dr. Materin shares insights into his recent transition from Duke University to Northwell Health, what inspired the move, and what it means for patients seeking ocular melanoma care. We also discuss his approach to treating ocular melanoma, the importance of personalized patient care, and how he works alongside patients and families facing a rare cancer diagnosis. But this series is about more than credentials and clinical expertise. Get to know Dr. Materin on a personal level as he reflects on his journey into medicine, the experiences that shaped his career, and the passions that drive his work today. Whether you're a patient, caregiver, advocate, or healthcare professional, this episode offers a unique opportunity to connect with one of the experts helping lead the way in ocular melanoma care. 🎧 Listen, learn, and get to know the people behind the white coats. Learn more about A Cure In Sight: https://acureinsight.org Thank you to our sponsors for making this possible! Ideaya Biosciences Delcath Systems Aura Biosciences Castle Biosciences Immunocore Natera Rare Cancer. Resilient Hope. Revolutionary Research. #OcularMelanoma #EyeBelievePodcast #WhatsUpDoc #MiguelMaterin #NorthwellHealth #OcularOncology #RareCancer #EyeCancer #ACureInSight

In this Eye on the Expert webinar, Eye on CHOPIN: Study Insights & Personalizing Treatment in MUM, three leading U.S. physicians discuss the latest findings from the CHOPIN trial, with results reported in late 2025. This recorded discussion explores how emerging data can support a more individualized approach to treating metastatic uveal melanoma (MUM), helping clinicians and patients make more informed, personalized decisions. In this webinar, experts cover: Key insights and takeaways from the CHOPIN trial How treatment can be tailored based on patient needs and preferences The importance of shared decision-making in MUM care Options for patients who may not be eligible for—or choose not to pursue—certain therapies Whether you are a patient, caregiver, or healthcare professional, this webinar offers valuable perspective on how research is shaping more personalized treatment pathways in uveal melanoma. 🎧 Watch now to learn how CHOPIN trial insights are helping guide the future of MUM care.

In this episode of the Eye Believe Podcast, Danet sits down with Dr. Vincent Ma to discuss an emerging and exciting tool in cancer monitoring: ctDNA (circulating tumor DNA)—or as Dr. Ma memorably calls it, “cancer poop.” Dr. Ma breaks down this complex topic in a way that’s easy to understand, explaining: What ctDNA is and how it works How it can be tested and monitored over time How he’s using ctDNA in his practice to better track disease and guide care for his patients This conversation offers a unique look at how innovative science is becoming more accessible—and how tools like ctDNA may help improve early detection, monitoring, and personalized treatment strategies. Whether you’re a patient, caregiver, or simply curious about the future of cancer care, this episode provides valuable insight into a rapidly evolving area of research. Tune in to learn how something as unexpected as “cancer poop” could play an important role in advancing cancer care.